Here are 3 top ASX growth shares that analysts rate as buys

These top growth shares are rated as buys…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

If you're interested in adding some ASX growth shares to your portfolio, you may want to look at the three listed below.

These growth shares have recently been named as buys by experts. Here's what they are saying about them:

A smiling man points upwards with both fingers in an exaggerated sideways pose.

Image source: Getty Images

Aristocrat Leisure Limited (ASX: ALL)

The first ASX growth share that has been tipped as a buy is Aristocrat Leisure. It is one of the world's leading gaming technology companies and the owner of a portfolio of popular poker machines and digital games. The latter boasts over ~20 million monthly active users and are generating significant recurring revenues. Aristocrat is also looking to expand into the real money gaming market, which could be another significant avenue of growth.

Citi is a fan of the company. It has a buy rating and $40.20 price target on its shares.

Cochlear Limited (ASX: COH)

Another ASX growth share that has been named as a buy is Cochlear. It is one of the world's leading hearing solutions companies. Thanks to its portfolio of world class products in an industry with high barriers of entry, Cochlear has been growing at a solid rate for well over a decade and looks well-placed to continue this trend in the future. Particularly given how the industry is benefiting from favourable tailwinds such as ageing populations.

Goldman Sachs is bullish on Cochlear. Its analysts currently have a buy rating and $237.00 price target on its shares.

Webjet Limited (ASX: WEB)

A final ASX growth share that has been named as a buy is online travel agent Webjet. After a tough couple of years, Webjet is now back on form thanks to rebounding travel markets. And with its costs reduced materially from pre-pandemic levels, Webjet looks set to be a much more efficient business in the future. This bodes well for its growth in the coming years.

Goldman Sachs is also very positive on Webjet. Its analysts currently have a buy rating and $6.80 price target on its shares.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Cochlear Ltd. The Motley Fool Australia has recommended Cochlear Ltd. and Webjet Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

A golden egg with dividend cash flying out of it
Growth Shares

Forget Easter eggs, these ASX shares could be your best buys this month

These shares could be top buys after the Easter break.

Read more »

Two smiling work colleagues discuss an investment at their office.
Growth Shares

3 amazing ASX growth shares I'd buy and hold for the next decade

These shares could be worth holding tightly to for the long term.

Read more »

Wife and husband with a laptop on a sofa over the moon at good news.
Growth Shares

$5,000 invested in Droneshield shares 4 months ago is already worth…

Investors will be thrilled!

Read more »

Person with a handful of Australian dollar notes, symbolising dividends.
Dividend Investing

1 ASX dividend share and 1 ASX growth stock to buy in April

These ASX shares deliver a one-two punch: income now, growth later.

Read more »

Increasing white bar graph with a rising arrow on an orange background.
Growth Shares

Here's what I consider to be the very best ASX 200 share to buy in April

This business looks heavily undervalued to me.

Read more »

Scared people on a rollercoaster holding on for dear life, indicating a plummeting share price
Growth Shares

3 reasons to buy this red-hot ASX healthcare stock today

Brokers think the biotech share is gearing up for its next big move.

Read more »

Multi-ethnic people looking at a camera in a public place and screaming, shouting, and feeling overjoyed.
Growth Shares

2 ASX stocks that could help turn $10,000 into $1 million

I’d think about adding these ASX shares to your portfolio.

Read more »

Part of male mannequin dressed in casual clothes holding a sale paper shopping bag.
Growth Shares

2 ASX financial stocks that could double – or even triple – in value

If sentiment turns and execution delivers, this could be an opportunity investors won’t want to miss.

Read more »